| # | Company | Location | Employees | Total Funding | Last Round | Last Funded |
|---|---|---|---|---|---|---|
| 1 |
Mediar Therapeutics
Mediar is a pre-clinical stage biotechnology company developing therapeutics for…
|
Cambridge | 11 - 50 | $181.0M | Series B | 2026-01-07 |
| 2 |
Ventyx Biosciences
Ventyx is a biopharmaceutical company focused on advancing oral therapies for pa…
|
San Diego | 101 - 250 | $468.6M | Post Ipo Equity | 2024-09-23 |
| 3 |
Rakuten Medical
Rakuten Medical is a biotechnology company developing investigational cancer the…
|
San Diego | 101 - 250 | $837.6M | Corporate Round | 2026-04-02 |
| 4 |
Sanofi
Sanofi is a global biopharma company focused on prescription drugs, vaccines, an…
|
Paris | c 10001 max | $7.0B | Post Ipo Debt | 2025-10-28 |
| 5 |
BioAge Labs
BioAge Labs is a clinical-stage biotechnology company that develops therapeutics…
|
Richmond | 51 - 100 | $408.9M | Post Ipo Equity | 2026-01-21 |
| 6 |
Diagonal Therapeutics
Diagonal Therapeutics is a biotechnology startup that develops targeted therapie…
|
Watertown | 11 - 50 | $253.0M | Series B | 2026-01-08 |
| 7 |
Talkspace
Talkspace is a digital therapy company that offers online therapy, online counse…
|
New York | 501 - 1K | $413.7M | Post Ipo Equity | 2021-06-23 |
| 8 |
Ukko
Ukko is a biotechnology company focused on developing immunotherapies for the tr…
|
Palo Alto | 11 - 50 | $92.7M | Series C | 2026-01-08 |
| 9 |
Invivyd
Invivyd develops antibodies to transcend the limitations of the human immune sys…
|
Waltham | 101 - 250 | $678.5M | Post Ipo Equity | 2025-11-17 |
| 10 |
Kinaset Therapeutics
Kinaset Therapeutics is a biopharma company that focuses on advancement of novel…
|
Boston | 1 - 10 | $144.5M | Series B | 2026-01-10 |
| 11 |
ImmunityBio
ImmunityBio is a late-stage immunotherapy startup that is developing treatments …
|
Culver City | 501 - 1K | $1.4B | Post Ipo Equity | 2025-07-25 |
| 12 |
Omada Health
Omada Health is a digital behavioral medicine company that helps members change …
|
San Francisco | 501 - 1K | $528.5M | Secondary Market | 2025-05-27 |
| 13 |
Aclarion
Aclarion is a healthcare technology company that assists with medical imaging an…
|
Broomfield | 11 - 50 | $48.4M | Post Ipo Equity | 2026-01-08 |
| 14 |
Tessera Therapeutics
Tessera Therapeutics is a biotechnology company pioneering Gene Writing™ to driv…
|
Cambridge | 251 - 500 | $773.1M | Grant | 2026-03-23 |
| 15 |
Variant Bio
Variant Bio is leveraging the power of human genetic diversity to discover new t…
|
Seattle | 11 - 50 | $129.7M | Series B | 2021-11-09 |
| 16 |
Beacon Therapeutics
Beacon Therapeutics is a biotechnology company that develops treatments to prese…
|
Alachua | 101 - 250 | $365.1M | Series C | 2026-01-08 |
| 17 |
AirNexis Therapeutics
AirNexis Therapeutics develops clinical-stage therapies for chronic obstructive …
|
Palo Alto | — | $200.0M | Series A | 2026-01-09 |
| 18 |
Kyverna Therapeutics
Kyverna Therapeutics is pioneering a new class of therapies and cures for seriou…
|
Berkeley | 101 - 250 | $295.0M | Post Ipo Equity | 2025-12-17 |
| 19 |
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery,…
|
Cambridge | 1K - 5K | $4.5B | Post Ipo Debt | 2025-09-09 |
| 20 |
Lisata Therapeutics
Lisata Therapeutics is a clinical-stage biopharmaceutical company.
|
Basking Ridge | 11 - 50 | $165.6M | Grant | 2021-05-12 |
| 21 |
EpiBiologics
EpiBiologics develops antibody-based targeted therapies against membrane and ext…
|
San Mateo | 11 - 50 | $203.1M | Series B | 2026-01-08 |
| 22 |
Cellares
Cellares is an Integrated Development and Manufacturing Organization dedicated t…
|
South San Francisco | 101 - 250 | $612.0M | Series C | 2023-08-23 |
| 23 |
Poplar Therapeutics
Poplar Therapeutics anti-IgE therapy treats atopic diseases such as food allergy…
|
Cambridge | 1 - 10 | $50.0M | Series A | 2026-01-07 |
| 24 |
Soley Therapeutics
Soley Therapeutics combines AI with molecular and cellular response detection fo…
|
San Francisco | 11 - 50 | $220.0M | Series C | 2026-01-07 |
| 25 |
BlossomHill Therapeutics
BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and…
|
San Diego | 11 - 50 | $257.0M | Series B | 2025-12-10 |
| 26 |
Tahoe Therapeutics
Tahoe Therapeutics is a biotechnology company that develops AI models of human c…
|
South San Francisco | 11 - 50 | $42.0M | Series A | 2025-08-11 |
| 27 |
Think Bioscience
Think Bioscience is reimagining synthetic biology by guiding the design and asse…
|
Boulder | 11 - 50 | $78.3M | Series A | 2026-01-20 |
| 28 |
CAMP4 Therapeutics
CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy g…
|
Cambridge | 11 - 50 | $270.0M | Post Ipo Equity | 2025-12-18 |
| 29 |
InduPro
InduPro deevlops proximity-based protein therapeutics that modulate cell-surface…
|
Seattle | 11 - 50 | $85.0M | Corporate Round | 2026-01-07 |
| 30 |
Mirador Therapeutics
Mirador Therapeutics develops precision medicines for immune-mediated diseases.
|
San Diego | 11 - 50 | $730.0M | Series B | 2026-01-12 |
| 31 |
Midi Health
Midi Health provides virtual care for women in midlife, offering clinician suppo…
|
Los Angeles | 101 - 250 | $252.0M | Series D | 2026-02-03 |
| 32 |
Insitro
Insitro is a drug discovery and development startup that utilizes machine learni…
|
South San Francisco | 251 - 500 | $643.0M | Series C | 2021-03-15 |
| 33 |
Replicate Bioscience
Replicate Bioscience develops self-replicating RNA therapeutics and vaccines del…
|
San Diego | 11 - 50 | $53.0M | Grant | 2026-01-08 |
| 34 |
Ambros Therapeutics
Ambros Therapeutics is a clinical-stage biotechnology company.
|
Irvine | 11 - 50 | $125.0M | Series A | 2025-12-16 |
| 35 |
Tivic Health
Tivic Health is a commercial health tech company that develops bioelectronic med…
|
Menlo Park | 11 - 50 | $81.0M | Post Ipo Equity | 2025-12-11 |
| 36 |
Scribe Therapeutics
Scribe Therapeutics is a biotech company that develops and engineers new therape…
|
Alameda | 51 - 100 | $120.0M | Convertible Note | 2023-05-16 |
| 37 |
Sword Health
Sword Health offers AI-powered physical therapy solutions for pain recovery at h…
|
New York | 1K - 5K | $493.5M | Series Unknown | 2025-06-17 |
| 38 |
Sanegene Bio
Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinica…
|
Woburn | 51 - 100 | $240.0M | Series B | 2025-12-08 |
| 39 |
DISCO Pharmaceuticals
DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unloc…
|
Cologne | 11 - 50 | $64.0M | Seed | 2025-12-11 |
| 40 |
Massive Bio
Massive Bio is an AI powered oncology platform that connects patients to clinica…
|
New York | 101 - 250 | $23.8M | Series B | 2022-06-02 |
| 41 |
Nimbus Therapeutics
Nimbus Therapeutics uses computational technology to create selective small mole…
|
Boston | 51 - 100 | $637.0M | Private Equity | 2023-09-06 |
| 42 |
Alloy Therapeutics
Alloy Therapeutics is a biotech company that makes medicine by democratizing acc…
|
Waltham | 11 - 50 | $128.2M | Series E | 2026-04-15 |
| 43 |
OS Therapies
OS Therapies is a therapeutics company focused on the identification, developmen…
|
Rockville | 1 - 10 | $37.1M | Post Ipo Equity | 2026-04-02 |
| 44 |
Tubulis
Tubulis generates antibody-drug conjugates with unique properties for solid tumo…
|
Munich | 51 - 100 | $616.9M | Series C | 2025-10-15 |
| 45 |
Atavistik Bio
Atavistik Bio is a biotechnology company that develops precision allosteric smal…
|
Cambridge | 11 - 50 | $260.0M | Series B | 2026-03-05 |
| 46 |
Metagenomi
Metagenomi uses metagenomics and machine learning to discover novel genome editi…
|
Emeryville | 101 - 250 | $457.0M | Series B | 2023-01-05 |
| 47 |
Encoded Therapeutics
Encoded Therapeutics is a Harnessing the regulatory genome to create next-genera…
|
South San Francisco | 101 - 250 | $239.1M | Series D | 2021-03-15 |
| 48 |
Vida Health
Vida Health is a virtual care platform that provides health coaching from experi…
|
San Francisco | 251 - 500 | $216.5M | Series Unknown | 2023-11-09 |
| 49 |
PhaseV
PhaseV provides AI-driven solutions for efficient clinical development and opera…
|
Boston | 11 - 50 | $65.0M | Series A | 2025-05-13 |
| 50 |
Aspen Neuroscience
Aspen Neuroscience is a biotechnology company that specializes in personalized c…
|
San Diego | 101 - 250 | $387.0M | Series C | 2025-11-20 |